4.0
Jun 11, 2025
Current employee, more than 1 year
Recommend
CEO approval
Business outlook
Pros
reasonable leadership, relatively responsive (depending on region)
Cons
aquired by Boston Scientific - major changes underway - going well so far but everything is shifting from startup culture to BIG corporate red tape land